PCRX Pacira BioSciences, Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 4, 2026
$25.21
· of 52w range
· above low
· to high
$18.8052w low
$27.6652w high
Market Cap (MRQ)
$1.00B
P/E (TTM)
70.0
EPS (TTM)
$0.36
Revenue (TTM)
$746M
your badges
52W Range
$19–$28
Analyst Rating
BUY
Price Target
$30
P/E
70.0
ROE
2.0%
Net Profit Margin
2.0%
Your badge strip is empty — pin a metric anywhere on this page.
PCRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$25.21
Market Cap (MRQ)
$1.00B
P/E (TTM)
70.0
EPS (TTM)
$0.36
Revenue (TTM)
$746M
ROE (TTM)
2.0%
Debt/Equity (MRQ)
0.5
52W Range
$19–$28
PCRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$726M2016-12-31 → 2025-12-31
EPS$0.162016-12-31 → 2025-12-31
Free Cash Flow$137M2016-12-31 → 2025-12-31
Net margin2.0%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PCRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 70.05Y avg ≈74.0 | ≈74.0 | · | · | |
| P/S (TTM) | 1.35Y avg ≈2.5 | ≈2.5 | · | · | |
| P/B (MRQ) | 1.55Y avg ≈2.1 | ≈2.1 | 3.7 | Undervalued | |
| EV / EBITDA (TTM) | 10.6 | · | · | · | |
| Price / FCF (TTM) | 5.65Y avg ≈14.6 | ≈14.6 | · | · | |
| Price / Cash Flow (TTM) | 5.35Y avg ≈11.1 | ≈11.1 | · | · | |
| EV / Revenue (TTM) | 1.5 | · | · | · | |
| EV / FCF (TTM) | 6.2 | · | · | · | |
| Price / Tangible Book (MRQ) | 2.65Y avg ≈9.5 | ≈9.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PCRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 2.7%5Y avg ≈10.3% | ≈10.3% | -2342.9% | Top tier | |
| EBITDA Margin (TTM) | 14.1%5Y avg ≈21.0% | ≈21.0% | -1487.9% | Top tier | |
| Pretax Margin (TTM) | 2.4%5Y avg ≈6.0% | ≈6.0% | -414.1% | Top tier | |
| Net Profit Margin (TTM) | 2.0%5Y avg ≈4.3% | ≈4.3% | -1320.1% | Top tier | |
| ROA (TTM) | 1.1%5Y avg ≈0.01% | ≈0.01% | -34.1% | Top tier | |
| ROE (TTM) | 2.0%5Y avg ≈0.14% | ≈0.14% | -39.7% | Top tier | |
| ROIC | 0.75%5Y avg ≈2.2% | ≈2.2% | -30.5% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PCRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.5 | · | 0.3 | High debt | |
| Current Ratio (MRQ) | 5.05Y avg ≈3.4 | ≈3.4 | 10.1 | Low liquidity | |
| Quick Ratio (MRQ) | 3.15Y avg ≈2.6 | ≈2.6 | 9.0 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.5 | · | 0.3 | High debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | PCRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 3.6%5Y avg ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y | 2.9%5Y avg ≈9.4% | ≈9.4% | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | |
| EPS YoY | 161.8%5Y avg ≈8.8% | ≈8.8% | · | · | |
| Net Income YoY | 163.7%5Y avg ≈10.2% | ≈10.2% | · | · | |
| EPS CAGR 3Y | -22.2% | · | · | · | |
| EPS CAGR 5Y | -45.5% | · | · | · | |
| Net Income CAGR 3Y | -23.8% | · | · | · | |
| Net Income CAGR 5Y | -45.4% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | PCRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.55Y avg ≈0.4 | ≈0.4 | 0.2 | Top tier | |
| Inventory Turnover | 1.15Y avg ≈1.6 | ≈1.6 | · | · | |
| Receivables Turnover | 6.15Y avg ≈6.7 | ≈6.7 | 11.6 | Weak | |
| Revenue / Employee | ≈$880.5K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-2.3%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 3, 2026 | $0.73 | $0.66 | 10.6% |
| March 31, 2026 | May 6, 2026 | $0.60 | $0.57 | 4.4% |
| Dec. 31, 2025 | $0.57 | $0.92 | -38.2% | |
| Sept. 30, 2025 | $0.70 | $0.66 | 5.3% | |
| June 30, 2025 | $0.74 | $0.72 | 2.1% | |
| March 31, 2025 | $0.62 | $0.61 | 2.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $726M | $701M | $675M | $667M | $542M | $430M | $421M | $337M | $287M | $276M | $249M | $198M | |
| Cost of Revenue | $150M | $170M | $185M | $199M | $140M | $117M | $107M | $87M | $88M | $110M | $72M | $77M | |
| R&D Expense | $117M | $82M | $76M | $85M | $56M | $59M | $72M | $56M | $57M | $46M | $29M | $19M | |
| SG&A Expense | $369M | $294M | $269M | $255M | $199M | $194M | $201M | $177M | $161M | $153M | $139M | $107M | |
| Operating Expenses | $707M | $774M | $587M | $607M | $452M | $383M | $411M | $321M | $312M | $308M | $240M | $203M | |
| Operating Income | $19M | $-73M | $88M | $60M | $90M | $46M | $10M | $16M | $-25M | $-32M | $9M | $-5M | |
| Interest Expense | · | · | $20M | $40M | $32M | $26M | $24M | $22M | $18M | $7M | $8M | $8M | |
| Interest Income | $23M | $20M | $11M | $5M | $896.0K | $5M | $7M | $6M | $4M | $1M | $678.0K | $382.0K | |
| Other Non-op | $-7M | $-373.0K | $-186.0K | $-11M | $-3M | $3M | $-5M | $-888.0K | $167.0K | $-82.0K | $-165.0K | $-159.0K | |
| Pretax Income | $17M | $-63M | $62M | $13M | $56M | $20M | $-11M | $-425.0K | $-42M | $-38M | $2M | $-14M | |
| Income Tax | $10M | $36M | $20M | $-3M | $14M | $-125M | $268.0K | $46.0K | $140.0K | $105.0K | $264.0K | $173.0K | |
| Net Income | $7M | $-100M | $42M | $16M | $42M | $146M | $-11M | $-471.0K | $-43M | $-38M | $2M | $-14M | |
| EPS (Basic) | $0.16 | $-2.15 | $0.91 | $0.35 | $0.95 | $3.41 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.05 | $-0.39 | |
| EPS (Diluted) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 | $3.33 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.04 | $-0.39 | |
| Shares (Basic) | 44,566,000 | 46,245,000 | 46,222,000 | 45,521,000 | 44,262,000 | 42,671,000 | 41,513,000 | 40,911,000 | 39,806,000 | 37,236,000 | 36,540,000 | 35,299,000 | |
| Shares (Diluted) | 45,042,000 | 46,245,000 | 51,979,000 | 46,538,000 | 45,630,000 | 43,682,000 | 41,513,000 | 40,911,000 | 39,806,000 | 37,236,000 | 41,301,000 | 35,299,000 | |
| EBITDA | $110M | $5M | $163M | $152M | $118M | $66M | $30M | $29M | $-11M | $-19M | $21M | $5M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $159M | $277M | $153M | $104M | $586M | $100M | $78M | $133M | $54M | $36M | $54M | $38M | |
| Short-term Investments | $80M | $208M | $125M | $185M | $71M | $422M | $214M | $251M | $257M | $137M | $102M | $119M | |
| Receivables | $124M | $113M | $106M | $98M | $96M | $53M | $48M | $38M | $32M | $30M | $26M | $22M | |
| Inventory | $153M | $125M | $104M | $96M | $99M | $65M | $58M | $49M | $41M | $31M | $62M | $29M | |
| Prepaid Expense | $33M | $22M | $22M | $15M | $15M | $12M | $11M | $8M | $7M | $9M | $6M | $4M | |
| Current Assets | $548M | $745M | $510M | $498M | $866M | $652M | $409M | $478M | $391M | $243M | $253M | $214M | |
| PP&E (Net) | $141M | $167M | $174M | $184M | $188M | $137M | $105M | $109M | $107M | $101M | $90M | $61M | |
| PP&E (Gross) | $278M | $300M | $309M | $301M | $274M | $215M | $180M | $170M | $156M | $139M | $115M | $81M | |
| Accum. Depreciation | $138M | $133M | $135M | $117M | $85M | $78M | $75M | $62M | $49M | $38M | $25M | $20M | |
| Goodwill | $20M | $0 | $163M | $163M | $145M | $100M | $100M | $62M | $55M | $47M | $31M | $24M | |
| Intangibles | $368M | $426M | $483M | $541M | $624M | $97M | $104M | $0 | · | $0 | $81.0K | $403.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | $657.0K | $825.0K | $624.0K | $406.0K | $3M | |
| Total Assets | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831M | $689M | $628M | $391M | $388M | $326M | |
| Accounts Payable | $15M | $19M | $16M | $15M | $11M | $10M | $13M | $14M | $15M | $8M | $9M | $7M | |
| Accrued Liabilities | $96M | $80M | $64M | $90M | $128M | $71M | $70M | $46M | $41M | $37M | $35M | $28M | |
| Current Liabilities | $121M | $310M | $97M | $148M | $521M | $253M | $108M | $61M | $56M | $45M | $150M | $140M | |
| Capital Leases | $36M | $45M | $55M | $65M | $72M | $71M | $41M | $0 | · | · | · | · | |
| Deferred Tax | $4M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $21M | $17M | $14M | $10M | $20M | $4M | $2M | $17M | $16M | $19M | $11M | $5M | |
| Total Liabilities | $572M | $775M | $704M | $906M | $1.34B | $655M | $476M | $368M | $349M | $172M | $169M | $155M | |
| Long-term Debt | $372M | $585M | $522M | $689M | · | · | · | · | · | $109M | $104M | $103M | |
| Total Debt | $372M | · | · | · | · | · | · | · | · | $119M | $119M | $120M | |
| Common Stock | $48.0K | $47.0K | $46.0K | $46.0K | $45.0K | $44.0K | $42.0K | $41.0K | $41.0K | $37.0K | $37.0K | $36.0K | |
| Paid-in Capital | $1.06B | $1.01B | $977M | $924M | $942M | $873M | $754M | $710M | $669M | $565M | $527M | $481M | |
| Retained Earnings | $-199M | $-206M | $-107M | $-149M | $-212M | $-254M | $-399M | $-388M | $-389M | $-346M | $-308M | $-310M | |
| Treasury Stock | $177M | $25M | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $4M | $343.0K | $247.0K | $-380.0K | $167.0K | $318.0K | $322.0K | $-280.0K | $-454.0K | $-30.0K | $-52.0K | $-80.0K | |
| Stockholders' Equity | $693M | $778M | $870M | $775M | $730M | $620M | $355M | $321M | $279M | $219M | $218M | $171M | |
| Liabilities + Equity | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831M | $689M | $628M | $391M | $388M | $326M | |
| Shares Outstanding | 41,116,739 | 47,078,000 | 46,481,000 | 45,928,000 | 44,734,000 | 43,637,000 | 41,908,148 | 41,222,799 | 40,668,877 | 37,480,952 | 36,848,319 | 36,150,620 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $91M | $79M | $76M | $92M | $29M | $20M | $20M | $13M | $14M | $13M | $11M | $10M | |
| Stock-based Comp | $58M | $51M | $48M | $48M | $42M | $40M | $34M | $32M | $32M | $31M | $33M | $25M | |
| Deferred Tax | $6M | $21M | $16M | $-8M | $11M | $-127M | $-2M | $0 | $0 | · | · | · | |
| Amort. of Intangibles | $57M | $57M | $57M | $57M | $14M | $8M | $6M | $0 | $0 | $100.0K | $300.0K | $800.0K | |
| Restructuring | $4M | $9M | $1M | $0 | $0 | $-38.0K | $847.0K | $2M | · | · | · | · | |
| Other Non-cash | $-10M | $138M | $-26M | $-2M | $2M | $-2M | $30M | $4M | $15M | $27M | $-18M | $4M | |
| Operating Cash Flow | $152M | $189M | $155M | $145M | $126M | $77M | $71M | $49M | $18M | $33M | $28M | $27M | |
| CapEx | $15M | $11M | $15M | $30M | $46M | $38M | $10M | $15M | $19M | $25M | $40M | $23M | |
| Investing Cash Flow | $99M | $-83M | $78M | $-225M | $-21M | $-278M | $-128M | $21M | $-224M | · | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $-4.0K | $-1M | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $-4.0K | $-1M | · | |
| Stock Repurchased | $148M | $25M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-148M | $-25M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-370M | $17M | $-183M | $-402M | $381M | $222M | $4M | $9M | $224M | · | · | · | |
| Net Change in Cash | $-118M | $123M | $49M | $-481M | $486M | $22M | $-54M | $78M | · | · | · | · | |
| Taxes Paid | $9M | $11M | $4M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $137M | $179M | $139M | $115M | $80M | $39M | $60M | $34M | $-1M | $9M | $-12M | $4M | |
| Levered FCF | · | · | $126M | $67M | $56M | $-147M | $36M | $10M | $-20M | $2M | $-19M | $-5M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.6% | · | 13.0% | 9.0% | 16.6% | 10.8% | 2.5% | 4.7% | -8.7% | -11.6% | 3.8% | -2.6% | |
| Net Margin | 0.97% | · | 6.2% | 2.4% | 7.8% | 33.9% | -2.6% | -0.14% | -14.9% | -13.7% | 0.75% | -6.9% | |
| Pretax Margin | 2.3% | · | 9.1% | 2.0% | 10.4% | 4.7% | -2.5% | -0.13% | -14.8% | -13.7% | 0.85% | -6.9% | |
| EBITDA Margin | 15.2% | · | 24.2% | 22.7% | 21.9% | 15.4% | 7.1% | 8.6% | -3.9% | -6.9% | 8.4% | 2.5% | |
| ROA | 0.50% | -6.4% | 2.6% | 0.85% | 2.5% | 13.8% | -1.5% | -0.07% | -8.4% | -9.7% | 0.52% | -5.5% | |
| ROE | 0.97% | -13.0% | 4.9% | 2.1% | 5.8% | 24.2% | -3.1% | -0.15% | -17.1% | -17.3% | 0.95% | -12.9% | |
| ROIC | 0.75% | -14.9% | 6.9% | 9.3% | 9.2% | 54.2% | 3.0% | 5.5% | -8.9% | -9.5% | 2.5% | -1.8% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 2.4 | 5.2 | 3.4 | 1.7 | 2.6 | 3.8 | 7.9 | 7.0 | 5.4 | 1.7 | 1.5 | |
| Quick Ratio | 3.0 | 1.9 | 3.9 | 2.6 | 1.4 | 2.3 | 3.2 | 6.9 | 6.1 | 4.5 | 1.2 | 1.3 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | 0.5 | 0.5 | 0.7 | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | 4.3 | 1.5 | 2.8 | 1.8 | 0.4 | 0.7 | -1.4 | -4.5 | 1.2 | -0.6 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | |
| Inventory Turnover | 1.1 | 1.5 | 1.8 | 2.0 | 1.7 | 1.9 | 2.0 | 1.9 | 2.4 | 2.4 | 1.6 | 3.5 | |
| Receivables Turnover | 6.1 | · | 6.6 | 6.8 | 7.3 | 8.5 | 9.8 | 9.7 | 9.3 | 9.9 | 10.3 | 10.7 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.86 | $16.83 | $18.72 | $16.87 | $16.33 | $14.20 | $8.47 | $7.79 | $6.87 | $5.84 | $5.93 | $4.73 | |
| Revenue / Share | $16.13 | · | $12.99 | $14.33 | $11.87 | $9.84 | $10.14 | · | $7.20 | $7.42 | $6.03 | · | |
| Cash Flow / Share | $3.37 | $4.10 | $2.98 | $3.12 | $2.76 | $1.76 | $1.70 | · | $0.45 | $0.90 | $0.70 | · | |
| Cash / Share | $3.86 | $5.99 | $3.30 | $2.27 | $13.09 | $2.29 | $1.87 | $3.21 | $1.33 | $0.96 | $1.55 | $1.04 | |
| EPS (TTM) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 | $3.33 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.04 | $-0.39 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.6% | 3.9% | 1.2% | 23.1% | 26.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.9% | 9.0% | 16.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | 161.8% | -63.0% | -72.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -22.2% | · | -35.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -45.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | 163.7% | -62.1% | -71.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -23.8% | · | -33.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -45.4% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $726M | $701M | $675M | $667M | $542M | $430M | $421M | $337M | $287M | $276M | $249M | $198M | |
| Net Income TTM | $7M | $-100M | $42M | $16M | $42M | $146M | $-11M | $-471.0K | $-43M | $-38M | $2M | $-14M | |
| Market Cap | $1.06B | $871M | $1.57B | $1.77B | $2.69B | $2.61B | $1.90B | $1.77B | $1.86B | $1.21B | $2.83B | $3.21B | |
| Enterprise Value | $1.20B | · | · | · | · | · | · | · | · | $1.16B | $2.79B | $3.17B | |
| P/E | 161.8 | -8.8 | 37.9 | 113.6 | 65.4 | 18.0 | -167.8 | -4302.0 | -42.7 | -31.7 | 1919.8 | -227.3 | |
| P/S | 1.5 | 1.2 | 2.3 | 2.7 | 5.0 | 6.1 | 4.5 | 5.3 | 6.5 | 4.4 | 11.4 | 16.2 | |
| P/B | 1.5 | 1.1 | 1.8 | 2.3 | 3.7 | 4.2 | 5.3 | 5.5 | 6.6 | 5.5 | 13.0 | 18.7 | |
| P / Tangible Book | 3.5 | 2.5 | 7.0 | 24.9 | · | 6.2 | · | · | · | · | · | · | |
| P / Cash Flow | 7.0 | 4.6 | 10.1 | 12.2 | 21.4 | 33.9 | 26.9 | 36.3 | 104.4 | 36.2 | 97.6 | 125.8 | |
| P / FCF | 7.8 | 4.9 | 11.2 | 15.4 | 33.7 | 66.6 | 31.5 | 51.6 | -1253.6 | 138.5 | -230.5 | 895.3 | |
| EV / EBITDA | 10.9 | · | · | · | · | · | · | · | · | -60.5 | 133.3 | 650.6 | |
| EV / FCF | 8.8 | · | · | · | · | · | · | · | · | 132.3 | -227.2 | 885.0 | |
| EV / Revenue | 1.6 | · | · | · | · | · | · | · | · | 4.2 | 11.2 | 16.0 | |
| Earnings Yield | 0.62% | -11.4% | 2.6% | 0.88% | 1.5% | 5.6% | -0.60% | -0.02% | -2.3% | -3.2% | 0.05% | -0.44% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $192M | $177M | $197M | $180M | $181M | $169M | $187M | $169M | $178M | $167M | $181M | $164M | $169M | $160M | · | $167M | |
| Cost of Revenue | $44M | $36M | $40M | $34M | $41M | $34M | $40M | $39M | $44M | $47M | $48M | $40M | $48M | $49M | $62M | $51M | |
| R&D Expense | $30M | $28M | $38M | $26M | $28M | $25M | $24M | $19M | $20M | $18M | $19M | $21M | $19M | $17M | $18M | $19M | |
| SG&A Expense | $92M | $94M | $102M | $92M | $89M | $87M | $80M | $74M | $68M | $72M | $66M | $68M | $65M | $71M | $64M | $61M | |
| Operating Expenses | $188M | $170M | $195M | $173M | $173M | $167M | $163M | $308M | $150M | $154M | $148M | $146M | $130M | $163M | · | $146M | |
| Operating Income | $4M | $7M | $2M | $6M | $8M | $2M | $25M | $-140M | $28M | $13M | $33M | $18M | $40M | $-3M | $-10M | $21M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $4M | $10M | · | $10M | |
| Interest Income | $2M | $2M | $2M | $9M | $5M | $7M | $6M | $5M | $5M | $4M | $3M | $3M | $2M | $3M | $3M | $1M | |
| Other Non-op | $-34.0K | $-135.0K | $-172.0K | $-110.0K | $-11M | $4M | $-53.0K | $-122.0K | $-39.0K | $-159.0K | $515.0K | $-422.0K | $-269.0K | $-10.0K | $81.0K | $-11M | |
| Pretax Income | $3M | $5M | $571.0K | $10M | $-2M | $9M | $26M | $-139M | $37M | $14M | $34M | $17M | $38M | $-26M | $-18M | $2M | |
| Income Tax | $-2M | $2M | $-1M | $4M | $3M | $4M | $9M | $5M | $18M | $5M | $9M | $6M | $12M | $-7M | $-8M | $3M | |
| Net Income | $5M | $3M | $2M | $5M | $-5M | $5M | $16M | $-143M | $19M | $9M | $25M | $11M | $26M | $-20M | $-10M | $-693.0K | |
| EPS (Basic) | $0.12 | $0.07 | $0.05 | $0.12 | $-0.11 | $0.10 | $0.36 | $-3.11 | $0.41 | $0.19 | $0.55 | $0.23 | $0.56 | $-0.43 | $-0.22 | $-0.02 | |
| EPS (Diluted) | $0.12 | $0.07 | $0.05 | $0.12 | $-0.11 | $0.10 | $0.38 | $-3.11 | $0.39 | $0.19 | $0.58 | $0.23 | $0.51 | $-0.43 | $-0.19 | $-0.02 | |
| Shares (Basic) | 39,462,000 | 40,461,000 | · | 44,038,000 | 45,459,000 | 46,275,000 | · | 46,134,000 | 46,174,000 | 46,499,000 | · | 46,416,000 | 46,088,000 | 45,949,000 | · | 45,831,000 | |
| Shares (Diluted) | 40,300,000 | 40,910,000 | · | 44,459,000 | 45,459,000 | 46,526,000 | · | 46,134,000 | 50,539,000 | 52,193,000 | · | 52,067,000 | 52,054,000 | 45,949,000 | · | 45,831,000 | |
| EBITDA | $4M | $28M | · | $6M | $8M | $23M | · | $-140M | $28M | $32M | · | $18M | $40M | $17M | · | $21M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $206M | $144M | $159M | $148M | $300M | $284M | $277M | $246M | $247M | $184M | · | $99M | $87M | $36M | · | $109M | |
| Short-term Investments | $45M | $58M | $80M | $99M | $145M | $210M | $208M | $208M | $157M | $142M | · | $136M | $134M | $138M | · | $219M | |
| Receivables | $132M | $126M | $124M | $115M | $114M | $105M | $113M | $101M | $105M | $102M | · | $97M | $99M | $93M | · | $93M | |
| Inventory | $135M | $150M | $153M | $158M | $148M | $134M | $125M | $112M | $103M | $97M | · | $97M | $92M | $93M | · | $97M | |
| Prepaid Expense | $30M | $37M | $33M | $43M | $37M | $28M | $22M | $24M | $20M | $19M | · | $19M | $17M | $16M | · | $14M | |
| Current Assets | $615M | $515M | $548M | $563M | $746M | $760M | $745M | $690M | $632M | $543M | · | $447M | $429M | $376M | · | $533M | |
| PP&E (Net) | $130M | $136M | $141M | $147M | $155M | $164M | $167M | $167M | $169M | $172M | · | $176M | $180M | $182M | · | $194M | |
| PP&E (Gross) | $281M | $281M | $278M | $280M | $308M | $304M | $300M | $297M | $293M | $292M | · | $307M | $308M | $305M | · | $295M | |
| Accum. Depreciation | $151M | $145M | $138M | $133M | $153M | $140M | $133M | $130M | $124M | $120M | · | $131M | $128M | $123M | · | $102M | |
| Goodwill | $20M | $20M | $20M | $20M | $20M | $22M | $0 | $0 | $163M | $163M | $163M | $163M | $163M | $163M | · | $157M | |
| Intangibles | $285M | $353M | $368M | $382M | $423M | $435M | $426M | $440M | $455M | $469M | · | $498M | $512M | $526M | · | $581M | |
| Total Assets | $1.24B | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B | $1.58B | · | $1.53B | $1.54B | $1.52B | · | $1.73B | |
| Accounts Payable | $18M | $14M | $15M | $18M | $30M | $23M | $19M | $19M | $19M | $9M | · | $17M | $24M | $17M | · | $13M | |
| Accrued Liabilities | $93M | $85M | $96M | $80M | $71M | $80M | $80M | $76M | $65M | $67M | · | $60M | $56M | $62M | · | $76M | |
| Current Liabilities | $122M | $109M | $121M | $107M | $313M | $315M | $310M | $306M | $93M | $93M | · | $94M | $109M | $99M | · | $132M | |
| Capital Leases | $39M | $34M | $36M | $39M | $41M | $44M | $45M | $48M | $50M | $52M | · | $57M | $60M | $62M | · | $65M | |
| Deferred Tax | $4M | $4M | $4M | $5M | $5M | $7M | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $27M | $25M | $21M | $25M | $25M | $24M | $17M | $13M | $13M | $13M | · | $12M | $12M | $12M | · | $19M | |
| Total Liabilities | $572M | $555M | $572M | $570M | $779M | $788M | $775M | $772M | $768M | $691M | · | $703M | $734M | $755M | · | $964M | |
| Long-term Debt | $363M | $368M | $372M | $377M | $580M | $583M | $585M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $363M | $368M | · | $377M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $49.0K | $48.0K | $48.0K | $48.0K | $48.0K | $47.0K | $47.0K | $47.0K | $47.0K | $47.0K | · | $46.0K | $46.0K | $46.0K | · | $46.0K | |
| Paid-in Capital | $1.09B | $1.07B | $1.06B | $1.05B | $1.04B | $1.02B | $1.01B | $996M | $983M | $990M | · | $963M | $951M | $936M | · | $909M | |
| Retained Earnings | $-192M | $-196M | $-199M | $-201M | $-206M | $-202M | $-206M | $-222M | $-79M | $-98M | · | $-132M | $-143M | $-168M | · | $-139M | |
| Treasury Stock | $227M | $227M | $177M | $126M | $76M | $25M | $25M | $25M | $25M | · | · | · | · | · | · | · | |
| AOCI | $3M | $3M | $4M | $4M | $4M | $1M | $343.0K | $678.0K | $105.0K | $152.0K | · | $-10.0K | $-173.0K | $-137.0K | · | $-670.0K | |
| Stockholders' Equity | $672M | $654M | $693M | $727M | $758M | $799M | $778M | $750M | $879M | $892M | $870M | $832M | $808M | $768M | $775M | $770M | |
| Liabilities + Equity | $1.24B | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B | $1.58B | · | $1.53B | $1.54B | $1.52B | · | $1.73B | |
| Shares Outstanding | 39,822,298 | 39,309,610 | 41,116,739 | 42,965,902 | 44,897,766 | 46,283,407 | 46,240,604 | 46,148,146 | 46,117,359 | 46,517,410 | 46,481,000 | 46,426,836 | 46,408,961 | 45,970,340 | 45,928,000 | 45,864,319 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $21M | $21M | $21M | $21M | $27M | $21M | $21M | $20M | $19M | $18M | $18M | $18M | $19M | $20M | $30M | $20M | |
| Stock-based Comp | $15M | $14M | $13M | $14M | $15M | $15M | $12M | $13M | $13M | $13M | $12M | $13M | $11M | $12M | $13M | $13M | |
| Deferred Tax | · | · | $-4M | $8M | $752.0K | $1M | $4M | $1M | $13M | $3M | $7M | $5M | $11M | $-7M | $-11M | $702.0K | |
| Amort. of Intangibles | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | |
| Restructuring | · | · | $-54.0K | $4M | $0 | $0 | $808.0K | $1M | $996.0K | $6M | $0 | $173.0K | $936.0K | · | $0 | $0 | |
| Other Non-cash | · | $-12M | · | · | · | $-6M | · | · | · | $5M | · | · | · | $14M | · | · | |
| Operating Cash Flow | $57M | $26M | $44M | $61M | $12M | $35M | $33M | $54M | $53M | $49M | $48M | $44M | $43M | $19M | $42M | $43M | |
| CapEx | $1M | $3M | $218.0K | $4M | $3M | $9M | $2M | $4M | $2M | $3M | $2M | $3M | $3M | $7M | $5M | $5M | |
| Investing Cash Flow | $12M | $19M | $19M | $44M | $62M | $-26M | $-368.0K | $-52M | $-15M | $-16M | $8M | $-4M | $7M | $66M | $11M | $-48M | |
| Stock Repurchased | $0 | $50M | $48M | $50M | $50M | $0 | $0 | $0 | · | · | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $-50M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-8M | $-59M | $-52M | $-257M | $-58M | $-3M | $-2M | $-3M | $25M | $-3M | $-2M | $-28M | $440.0K | $-154M | $-59M | $-8M | |
| Net Change in Cash | $62M | $-14M | $11M | $-153M | $17M | $7M | $31M | $-1M | $63M | $31M | $54M | $12M | $51M | $-69M | $-5M | $-13M | |
| Taxes Paid | $860.0K | $50.0K | $69.0K | $711.0K | $8M | $286.0K | $1M | $5M | $5M | $-245.0K | $2M | $1M | $594.0K | $201.0K | · | $112.0K | |
| Free Cash Flow | · | $23M | · | · | · | $27M | · | · | · | $46M | · | · | · | $13M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $44M | · | · | · | $5M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.2% | 3.9% | · | 3.5% | 4.7% | 1.2% | · | -82.8% | 15.9% | 7.9% | · | 10.8% | 23.5% | -1.9% | · | 12.7% | |
| Net Margin | 2.4% | 1.6% | · | 3.0% | -2.7% | 2.9% | · | -85.1% | 10.6% | 5.4% | · | 6.6% | 15.2% | -12.2% | · | -0.41% | |
| Pretax Margin | 1.3% | 2.8% | · | 5.3% | -1.1% | 5.1% | · | -82.4% | 20.5% | 8.2% | · | 10.1% | 22.3% | -16.5% | · | 1.2% | |
| EBITDA Margin | 2.2% | 15.9% | · | 3.5% | 4.7% | 13.7% | · | -82.8% | 15.9% | 18.9% | · | 10.8% | 23.5% | 10.3% | · | 12.7% | |
| ROA | 0.33% | 0.21% | · | 0.39% | -0.30% | 0.30% | · | -9.4% | 1.2% | 0.58% | · | 0.66% | 1.6% | -1.1% | · | -0.04% | |
| ROE | 0.65% | 0.40% | · | 0.74% | -0.59% | 0.57% | · | -18.1% | 2.2% | 1.1% | · | 1.4% | 3.3% | -2.6% | · | -0.09% | |
| ROIC | 0.75% | 0.39% | · | 0.33% | 2.8% | 0.14% | · | -19.2% | 1.7% | 0.97% | · | 1.4% | 3.4% | -0.30% | · | -0.93% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.7 | · | 5.3 | 2.4 | 2.4 | · | 2.3 | 6.8 | 5.8 | · | 4.8 | 3.9 | 3.8 | · | 4.1 | |
| Quick Ratio | 3.1 | 3.0 | · | 3.4 | 1.8 | 1.9 | · | 1.8 | 5.5 | 4.6 | · | 3.5 | 2.9 | 2.7 | · | 3.2 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 0.6 | · | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 4.0 | · | 5.1 | 10.3 | -0.3 | · | 2.2 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Receivables Turnover | 1.6 | 1.5 | · | 1.7 | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.7 | 1.8 | 1.7 | · | 2.3 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.87 | $16.63 | · | $16.93 | $16.88 | $17.25 | · | $16.24 | $19.07 | $19.18 | · | $17.91 | $17.41 | $16.71 | · | $16.79 | |
| Revenue / Share | $4.77 | $4.34 | · | $4.04 | $3.98 | $3.63 | · | $3.65 | $3.52 | $3.20 | · | $3.15 | $3.26 | $3.49 | · | $3.65 | |
| Cash Flow / Share | · | $0.63 | · | · | · | $0.76 | · | · | · | $0.94 | · | · | · | $0.42 | · | · | |
| Cash / Share | $5.17 | $3.67 | · | $3.44 | $6.69 | $6.13 | · | $5.33 | $5.36 | $3.96 | · | $2.13 | $1.87 | $0.77 | · | $2.39 | |
| EPS (TTM) | $0.36 | $0.13 | · | $0.49 | $-2.74 | $-2.24 | · | $-1.95 | $1.39 | $1.51 | · | $0.12 | $-0.13 | $-0.24 | · | $0.41 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $746M | $735M | · | $717M | $706M | $703M | · | $695M | $690M | $682M | · | · | · | · | · | $654M | |
| Net Income TTM | $15M | $5M | · | $21M | $-127M | $-104M | · | $-91M | $64M | $70M | · | $7M | $-5M | $-10M | · | $21M | |
| Market Cap | $1.01B | $888M | · | $1.11B | $1.07B | $1.15B | · | $695M | $1.32B | $1.36B | · | $1.42B | $1.86B | $1.88B | · | $2.44B | |
| Enterprise Value | $1.12B | $1.05B | · | $1.24B | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 70.5 | 173.8 | · | 52.6 | -8.7 | -11.1 | · | -7.7 | 20.6 | 19.4 | · | 255.7 | -308.2 | -170.0 | · | 129.7 | |
| P/S | 1.4 | 1.2 | · | 1.5 | 1.5 | 1.6 | · | 1.0 | 1.9 | 2.0 | · | · | · | · | · | 3.7 | |
| P/B | 1.5 | 1.4 | · | 1.5 | 1.4 | 1.4 | · | 0.9 | 1.5 | 1.5 | · | 1.7 | 2.3 | 2.4 | · | 3.2 | |
| P / Tangible Book | 2.8 | 3.2 | · | 3.4 | 3.4 | 3.4 | · | 2.2 | 5.0 | 5.2 | · | 8.3 | 14.0 | 23.9 | · | 76.8 | |
| P / Cash Flow | · | 34.6 | · | · | · | 32.4 | · | · | · | 27.7 | · | · | · | 98.1 | · | · | |
| EV / Revenue | 1.5 | 1.4 | · | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 1.4% | 0.58% | · | 1.9% | -11.5% | -9.0% | · | -13.0% | 4.9% | 5.2% | · | 0.39% | -0.32% | -0.59% | · | 0.77% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $726M | $701M | $675M | $667M | $542M |
| Operating Margin % | 2.6% | · | 13.0% | 9.0% | 16.6% |
| Net Income | $7M | $-100M | $42M | $16M | $42M |
| Diluted EPS | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.5 | · | · | · | · |
| Current Ratio | 4.5 | 2.4 | 5.2 | 3.4 | 1.7 |
| Quick Ratio | 3.0 | 1.9 | 3.9 | 2.6 | 1.4 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $137M | $179M | $139M | $115M | $80M |
Institutional owners (13F) 266 filers · $1.2B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
266
Value held
$1.2B
New positions
36
Exited positions
23
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 36 (0 vs prior Q) | 23 (-16 vs prior Q) | 79 (-8 vs prior Q) | 85 (+5 vs prior Q) | +308K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $170,126,377 | 6,705,809 | 14.10% | Shares |
| VANGUARD GROUP INC | $124,559,276 | 4,812,955 | 10.32% | Shares |
| Doma Perpetual Capital Management LLC | $70,472,634 | 2,777,794 | 5.84% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $61,046,258 | 2,406,238 | 5.06% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $53,360,107 | 2,103,245 | 4.42% | Shares |
| STATE STREET CORP | $52,261,616 | 2,059,977 | 4.33% | Shares |
| D. E. Shaw & Co., Inc. | $49,479,923 | 1,950,332 | 4.10% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $43,986,531 | 1,733,801 | 3.65% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $42,915,156 | 1,691,571 | 3.56% | Shares |
| GOLDMAN SACHS GROUP INC | $38,743,263 | 1,527,129 | 3.21% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $29,401,072 | 1,158,693 | 2.44% | Shares |
| MORGAN STANLEY | $29,039,913 | 1,144,654 | 2.41% | Shares |
| AMERICAN CENTURY COMPANIES INC | $25,829,019 | 1,018,093 | 2.14% | Shares |
| UBS Group AG | $23,345,905 | 920,217 | 1.94% | Shares |
| Impax Asset Management Group plc | $19,028,185 | 750,027 | 1.58% | Shares |
| TWO SIGMA INVESTMENTS, LP | $18,383,203 | 724,604 | 1.52% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17,525,241 | 690,786 | 1.45% | Shares |
| GAGNON SECURITIES LLC | $15,440,613 | 608,617 | 1.28% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $14,294,929 | 563,458 | 1.18% | Shares |
| NORTHERN TRUST CORP | $13,364,459 | 526,782 | 1.11% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $10,436,533 | 411,373 | 0.87% | Shares |
| DEUTSCHE BANK AG\ | $9,922,232 | 391,101 | 0.82% | Shares |
| Jefferies Financial Group Inc. | $9,389,234 | 370,092 | 0.78% | Shares |
| Hillsdale Investment Management Inc. | $9,201,699 | 362,700 | 0.76% | Shares |
| Gagnon Advisors, LLC | $8,946,401 | 352,637 | 0.74% | Shares |
| JPMORGAN CHASE & CO | $8,698,627 | 346,697 | 0.72% | Shares |
| EASTERLY INVESTMENT PARTNERS LLC | $8,550,172 | 337,019 | 0.71% | Shares |
| Bridge City Capital, LLC | $7,922,975 | 312,297 | 0.66% | Shares |
| BARCLAYS PLC | $7,869,496 | 310,189 | 0.65% | Shares |
| Bank of New York Mellon Corp | $7,531,837 | 296,880 | 0.62% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $7,129,402 | 281,017 | 0.59% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $6,633,164 | 261,457 | 0.55% | Shares |
| Invesco Ltd. | $6,326,010 | 249,350 | 0.52% | Shares |
| BANK OF AMERICA CORP /DE/ | $6,088,952 | 240,006 | 0.50% | Shares |
| MILLENNIUM MANAGEMENT LLC | $5,966,085 | 235,163 | 0.49% | Shares |
| Coppell Advisory Solutions LLC | $5,592,970 | 16 | 0.46% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $5,562,474 | 219,254 | 0.46% | Shares |
| FMR LLC | $5,505,316 | 217,001 | 0.46% | Shares |
| Empowered Funds, LLC | $5,075,852 | 200,073 | 0.42% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $5,068,926 | 199,800 | 0.42% | Shares |
| ROYAL BANK OF CANADA | $4,704,000 | 185,433 | 0.39% | Shares |
| Banco Santander, S.A. | $4,211,420 | 166,000 | 0.35% | Shares |
| Robeco Institutional Asset Management B.V. | $4,161,036 | 164,014 | 0.34% | Shares |
| AMERIPRISE FINANCIAL INC | $4,137,744 | 163,096 | 0.34% | Shares |
| CITADEL ADVISORS LLC | $4,114,101 | 162,164 | 0.34% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $4,021,427 | 158,511 | 0.33% | Shares |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3,562,811 | 140,434 | 0.30% | Shares |
| Public Sector Pension Investment Board | $3,429,720 | 135,188 | 0.28% | Shares |
| PDT Partners, LLC | $3,358,176 | 132,368 | 0.28% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $3,292,062 | 129,762 | 0.27% | Shares |
Activists & 5%+ owners 16 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| DOMA PERPETUAL CAPITAL MANAGEMENT LLC, DOMA1 LLC, DOMA Perpetual LO Equity Master Fund LP, DOMA Perpetual Partners GP LLC, Pedro Escudero, The John Templeton Foundation, DOMA2 LLC, Eric de Armas ×4 filings | March 12, 2026 | 7.30% | Amendment | Board campaign | SEC |
| Consonance Capital Management LP, Consonance Capman GP LLC, Mitchell Blutt ×5 filings | Sept. 6, 2019 | · | Initial filing | · | SEC |
| Undisclosed reporting person | March 18, 2014 | · | Initial filing | · | SEC |
| Undisclosed reporting person | July 26, 2013 | · | Initial filing | · | SEC |
| Undisclosed reporting person | April 2, 2013 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | March 21, 2013 | · | Initial filing | · | SEC |
| Sanderling Venture Partners VI, L.P., Sanderling Ventures Management VI, Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling VI Limited Partnership, Sanderling Venture Partners VI Co-Investment Fund, L.P., Middleton, McNeil, Mills & Associates VI, LLC, Fred A. Middleton ×4 filings | March 21, 2013 | · | Initial filing | Passive investment | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | Sept. 28, 2012 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | June 15, 2012 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | March 19, 2012 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | Dec. 1, 2011 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Dec. 1, 2011 | · | Initial filing | Passive investment | SEC |
| MPM BioVentures IV-QP, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, Todd Foley, James Paul Scopa, Vaughn M. Kailian, John Vander Vort | Nov. 29, 2011 | · | Initial filing | Passive investment | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | Feb. 18, 2011 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Feb. 18, 2011 | · | Initial filing | · | SEC |
| MPM BioVentures IV Q-P, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, William Greene, James Paul Scopa, Ashley Dombkowski, Vaughn M. Kailian, John Vander Vort | Feb. 18, 2011 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 44 insiders · 20 officers · 17 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Frank D. Lee | Chief Executive Officer | Feb. 11, 2026 A | 660,831 | 0 | 0 | $0 |
| David M Stack | CEO and Chairman | June 14, 2023 A | 186,481 | 0 | 0 | $0 |
| Shawn Cross | Chief Financial Officer | April 23, 2026 M | 105,341 | 0 | 7 | $-1,521,351 |
| Max Reinhardt | President, Rest of World | June 7, 2023 S | 29,225 | 0 | 0 | $0 |
| James S Scibetta | President | June 5, 2017 S | 25,118 | 0 | 0 | $0 |
| Scott Braunstein | Chief Operating Officer | Jan. 3, 2018 A | 20,982 | 0 | 0 | $0 |
| Jonathan Slonin | Chief Medical Officer | Aug. 17, 2026 S | 216,384 | 0 | 3 | $-240,431 |
| Lauren Riker | Senior Vice President, Finance | June 11, 2026 S | 62,284 | 0 | 3 | $-261,266 |
| Kristen Williams | Chief Administrative Officer | June 4, 2026 S | 167,062 | 0 | 2 | $-498,171 |
| Brendan Teehan | Chief Commercial Officer | Feb. 11, 2026 A | 100,934 | 0 | 0 | $0 |
| Ronald J. Ellis Jr. | Chief Strategy Officer | June 7, 2023 S | 30,909 | 0 | 0 | $0 |
| Dennis Mcloughlin | Chief Customer Officer | June 7, 2023 S | 38,115 | 0 | 0 | $0 |
| Anthony Molloy | Chief Lgl & Compliance Officer | June 6, 2023 S | 12,877 | 0 | 0 | $0 |
| Charles Anthony Laranjeira | Chief Technical Officer | June 14, 2022 M | 41,752 | 0 | 0 | $0 |
| Richard Scranton | Chief Scientific Officer | Nov. 8, 2019 M | 16,061 | 0 | 0 | $0 |
| Robert J. Weiland | Chief Commercial Officer | June 4, 2018 S | 5,088 | 0 | 0 | $0 |
| James B Jones | SVP & Chief Medical Officer | Nov. 20, 2017 S | 16,823 | 0 | 0 | $0 |
| Taunia Markvicka | SVP, Chief Commercial Officer | March 17, 2015 M | 8,579 | 0 | 0 | $0 |
| Gary Patou | Chief Medical Officer | Aug. 7, 2014 M | 0 | 0 | 0 | $0 |
| John Pratt | General Manager, San Diego | June 13, 2013 M | 0 | 0 | 0 | $0 |
| Marcelo Bigal | Director | June 10, 2026 A | 17,798 | 0 | 0 | $0 |
| Alethia Young | Director | June 10, 2026 A | 17,798 | 0 | 0 | $0 |
| Christopher Christie | Director | June 10, 2026 A | 23,059 | 0 | 0 | $0 |
| Samit Hirawat | Director | June 10, 2026 A | 6,405 | 0 | 0 | $0 |
| Mark Froimson | Director | June 10, 2026 A | 26,541 | 0 | 1 | $-10,905 |
| Michael J. Yang | Director | June 10, 2026 A | 19,798 | 0 | 0 | $0 |
| Laura Brege | Director | June 10, 2026 A | 30,120 | 0 | 0 | $0 |
| Thomas G Wiggans | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Mark A. Kronenfeld | Director | June 11, 2025 A | 31,065 | 0 | 0 | $0 |
| Yvonne Greenstreet | Director | June 8, 2022 A | 13,247 | 0 | 0 | $0 |
| John P Longenecker PHD | Director | March 3, 2022 M | 18,823 | 0 | 0 | $0 |
| Andreas Wicki | Director | March 15, 2021 S | 451,324 | 0 | 0 | $0 |
| Dennis L Winger | Director | June 14, 2017 A | 7,490 | 0 | 0 | $0 |
| Fred A Middleton | Director | June 24, 2013 S | 0 | 0 | 0 | $0 |
| Luke Evnin | Director | June 12, 2013 A | 0 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% owner | March 25, 2013 S | 2,233,993 | 0 | 0 | $0 |
| Abraham Ceesay | · | Sept. 4, 2025 S | 9,039 | 0 | 0 | $0 |
| Daryl Gaugler | · | Dec. 31, 2024 A | 115,443 | 0 | 0 | $0 |
| Charles A. Reinhart III | · | June 12, 2024 A | 51,867 | 0 | 0 | $0 |
| Paul J Hastings | · | June 12, 2024 A | 12,724 | 0 | 0 | $0 |
| Gary W Pace | · | March 8, 2024 S | 22,127 | 0 | 0 | $0 |
| Roy Winston | · | Aug. 2, 2023 S | 52,440 | 0 | 0 | $0 |
| Donald C. Manning | · | June 9, 2021 A | 29,520 | 0 | 0 | $0 |
| GORDON CARL L | · | Feb. 8, 2011 C | 2,828,941 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 58 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1.28% | 10,029 NS | July 31, 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0.74% | 8,394 NS | July 31, 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0.54% | 38,409 SH | Oct. 1, 2026 | Daily |
| RZG · Invesco Exchange-Traded Fund Trust | 0.50% | 23,694 SH | Oct. 1, 2026 | Daily |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.50% | 4,607 SH | Oct. 1, 2026 | Daily |
| XSHQ · Invesco Exchange-Traded Fund Trust … | 0.24% | 27,368 SH | Oct. 1, 2026 | Daily |
| SCOW · Pacer Funds Trust | 0.23% | 151 NS | July 31, 2026 | N-PORT |
| IHE · iShares Trust | 0.23% | 145,471 SH | Sept. 11, 2026 | Daily |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.18% | 39,523 NS | July 31, 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0.15% | 202,699 NS | July 31, 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.13% | 42,794 SH | Aug. 19, 2026 | Daily |
| FSMD · FIDELITY COVINGTON TRUST | 0.11% | 104,986 NS | July 31, 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.11% | 30,919 SH | Aug. 19, 2026 | Daily |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.11% | 46,835 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.08% | 87,939 SH | Oct. 1, 2026 | Daily |
| DFSV · Dimensional ETF Trust | 0.07% | 231,891 NS | July 31, 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.07% | 3,450 NS | July 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.07% | 2,809 SH | Oct. 1, 2026 | Daily |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.06% | 5,956 SH | Oct. 1, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.06% | 31,734 SH | Aug. 19, 2026 | Daily |
| ROSC · Lattice Strategies Trust | 0.05% | 1,241 NS | July 31, 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.05% | 137,158 SH | Aug. 19, 2026 | Daily |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.05% | 36,642 SH | Oct. 1, 2026 | Daily |
| VFQY · VANGUARD WELLINGTON FUND | 0.04% | 7,883 SH | Aug. 19, 2026 | Daily |
| DFAT · Dimensional ETF Trust | 0.04% | 204,980 NS | July 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.03% | 18,945 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.03% | 1,024,328 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 228,207 SH | Aug. 19, 2026 | Daily |
| PKW · Invesco Exchange-Traded Fund Trust | 0.03% | 19,840 SH | Oct. 1, 2026 | Daily |
| EBIT · Harbor ETF Trust | 0.02% | 106 NS | July 31, 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.02% | 542,974 SH | Aug. 19, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.02% | 2,098 SH | Oct. 1, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.02% | 90,095 NS | July 31, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 17,794 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 453,622 SH | Aug. 19, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.01% | 854,717 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.01% | 112,735 SH | Aug. 19, 2026 | Daily |
| TILT · FlexShares Trust | 0.01% | 7,900 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.01% | 2,019 SH | Sept. 11, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.01% | 118,628 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 1,277 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 6,433 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.01% | 28,461 SH | Sept. 11, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 9,932 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 69,932 SH | Sept. 11, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.00% | 12,671 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 12,150 SH | Sept. 11, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.00% | 866 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,198,792 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,506 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,388 SH | Aug. 19, 2026 | Daily |
| IJR · iShares Trust | · | 2,397,496 SH | Sept. 10, 2026 | Daily |
| IJT · iShares Trust | · | 374,609 SH | Sept. 9, 2026 | Daily |
| IWN · iShares Trust | · | 338,098 SH | Sept. 11, 2026 | Daily |
| XJR · iShares Trust | · | 5,453 SH | Aug. 31, 2026 | Daily |
| ISCB · iShares Trust | · | 1,678 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 8,216 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 12,184 SH | Aug. 19, 2026 | Daily |
PCRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 13 analysts
BUY
Median target
$30.00
+19.0%
3 23.1%
Strong Buy
6 46.2%
Buy
3 23.1%
Hold
1 7.7%
Sell
0 0.0%
Strong Sell
12-Month Price Target
9 analysts · 2026-10-01Mean target $30.00 +19.0%
Now
Current price $25.21
Low$23.00
Mean$30.00
High$38.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | · |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| YARW | · | · | · | · | · | · |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| SPTX | · | · | · | · | · | · |
| ANRO | $568M | -8.1 | · | · | -46.1% | · |
| ALMS | · | -3.4 | · | -1011.8% | -61.9% | · |
| APMD | · | · | · | · | · | · |
| SGP | · | · | · | · | 50.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 4, 2026